Miyanomori Memorial Hospital
Sapporo, Hokkaido 064-8570
0 studies enrolling now · 2 studies all time
What they study most
Atrial Fibrillation, Clostridium Difficile Infection, Prevention of Stroke or Systemic Embolism
Studies at this site
- A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early
- Clostridium Difficile Vaccine Efficacy Trial — Completed